Because AMPK induces tumor suppression, in part by facilitating p53 phosphorylation and stabilization [23], we next sought to determine whether aberrant AMPK activation in MIF/D-DT-deficient lung adenocarcinoma cells was responsible for the aberrant activation/stabilization of p53. The gene discussed is TP53; the disease is neoplasm.